Location: Greenwich, CT
CIK: 0001856083 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Sep 6, 2023
Total Value: $2.16B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1,250,000 | $155M | 7.2% | $142.14 | -5.3% | SHS USD | G50871105 |
| INSM | INSMED INC | 6,500,000 | $137M | 6.3% | $19.36 | -2.0% | COM PAR $.01 | 457669307 |
| IONS | IONIS PHARMACEUTICALS INC | 2,834,069 | $116M | 5.4% | $39.47 | -2.6% | COM | 462222100 |
| TVTX | TRAVERE THERAPEUTICS INC | 7,370,000 | $113M | 5.2% | $24.03 | -24.3% | COM | 89422G107 |
| GPCR | STRUCTURE THERAPEUTICS INC | 2,646,782 | $110M | 5.1% | $23.79 | — | SPONSORED ADS | 86366E106 |
| IMVT | IMMUNOVANT INC | 5,421,330 | $103M | 4.8% | $6.72 | +177.4% | COM | 45258J102 |
| — | INTRA-CELLULAR THERAPIES INC | 1,548,252 | $98.04M | 4.5% | $54.15 | — | COM | 46116X101 |
| ALKS | ALKERMES PLC | 3,000,000 | $93.9M | 4.3% | $27.24 | +11.1% | SHS | G01767105 |
| — | SPRINGWORKS THERAPEUTICS INC | 3,546,435 | $92.99M | 4.3% | $27.71 | — | COM | 85205L107 |
| — | DYNAVAX TECHNOLOGIES CORP | 6,557,816 | $84.73M | 3.9% | $10.20 | — | COM NEW | 268158201 |
| GERN | GERON CORP | 24,170,966 | $77.59M | 3.6% | $2.67 | +6.4% | COM | 374163103 |
| PLRX | PLIANT THERAPEUTICS INC | 4,050,000 | $73.39M | 3.4% | $23.88 | -0.9% | COM | 729139105 |
| BCYC | BICYCLE THERAPEUTICS PLC | 2,819,045 | $71.94M | 3.3% | $40.57 | — | SPONSORED ADS | 088786108 |
| — | VERONA PHARMA PLC | 3,187,415 | $67.38M | 3.1% | $12.01 | — | SPONSORED ADS | 925050106 |
| GH | GUARDANT HEALTH INC | 1,500,000 | $53.7M | 2.5% | $28.72 | 0.0% | COM | 40131M109 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,778,107 | $50.2M | 2.3% | $19.33 | -4.7% | COM | 35104E100 |
| — | AGENUS INC | 30,000,000 | $48M | 2.2% | $2.17 | — | COM NEW | 00847G705 |
| BEAM | BEAM THERAPEUTICS INC | 1,317,316 | $42.06M | 1.9% | $60.50 | -46.4% | COM | 07373V105 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 15,000,000 | $35.7M | 1.7% | $1.90 | — | SPON ADS | 05280R100 |
| NTLA | INTELLIA THERAPEUTICS INC | 835,446 | $34.07M | 1.6% | $51.69 | -21.5% | COM | 45826J105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,279,502 | $30.44M | 1.4% | $18.64 | +37.6% | COM | 92790C104 |
| NRIX | NURIX THERAPEUTICS INC | 2,997,830 | $29.95M | 1.4% | $11.16 | -8.7% | COM | 67080M103 |
| — | REPARE THERAPEUTICS INC | 2,727,606 | $28.86M | 1.3% | $18.55 | — | COM | 760273102 |
| EDIT | EDITAS MEDICINE INC | 3,453,744 | $28.42M | 1.3% | $8.71 | 0.0% | COM | 28106W103 |
| DYN | DYNE THERAPEUTICS INC | 2,499,912 | $28.12M | 1.3% | $12.12 | -2.7% | COM | 26818M108 |
| ANIP | ANI PHARMACEUTICALS INC | 514,021 | $27.67M | 1.3% | $44.33 | 0.0% | COM | 00182C103 |
| AXSM | AXSOME THERAPEUTICS INC | 384,200 | $27.61M | 1.3% | $73.77 | 0.0% | COM | 05464T104 |
| — | POINT BIOPHARMA GLOBAL INC | 2,781,565 | $25.2M | 1.2% | $7.55 | — | COM | 730541109 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,750,000 | $21.31M | 1.0% | $10.10 | -16.5% | COM | 28036F105 |
| ZURA | ZURA BIO LTD | 2,523,000 | $20.69M | 1.0% | $8.03 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,451,201 | $19.3M | 0.9% | $9.94 | +22.2% | COM | 69404D108 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 3,916,361 | $18.84M | 0.9% | $8.05 | -40.5% | COM | 00509G209 |
| — | RAPT THERAPEUTICS INC | 1,004,561 | $18.79M | 0.9% | $19.33 | — | COM | 75382E109 |
| PRTA | PROTHENA CORP PLC | 250,000 | $17.07M | 0.8% | — | — | Put | G72800108 |
| — | VIGIL NEUROSCIENCE INC | 1,773,409 | $16.67M | 0.8% | $8.83 | — | COM | 92673K108 |
| — | ASTRIA THERAPEUTICS INC | 1,697,415 | $14.14M | 0.7% | $14.89 | — | COM | 04635X102 |
| NUVB | NUVATION BIO INC | 7,720,688 | $13.9M | 0.6% | $4.49 | -62.1% | COM CL A | 67080N101 |
| — | MORPHIC HLDG INC | 216,752 | $12.43M | 0.6% | $57.33 | — | COM | 61775R105 |
| SLN | SILENCE THERAPEUTICS PLC | 1,951,580 | $10.73M | 0.5% | $16.79 | — | ADS | 82686Q101 |
| — | ORCHARD THERAPEUTICS PLC | 2,041,670 | $10.64M | 0.5% | $5.21 | — | SPON ADS NEW | 68570P101 |
| — | NEKTAR THERAPEUTICS | 17,973,464 | $10.34M | 0.5% | $0.59 | — | COM | 640268108 |
| TERN | TERNS PHARMACEUTICALS INC | 1,099,192 | $9.618M | 0.4% | $11.66 | 0.0% | COM | 880881107 |
| — | 89BIO INC | 503,100 | $9.534M | 0.4% | $7.98 | — | COM | 282559103 |
| — | INOZYME PHARMA INC | 1,644,021 | $9.157M | 0.4% | $4.77 | — | COM | 45790W108 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 300,300 | $8.471M | 0.4% | $23.99 | 0.0% | COM | 98943L107 |
| RLMD | RELMADA THERAPEUTICS INC | 2,837,818 | $6.981M | 0.3% | $10.86 | -74.5% | COM | 75955J402 |
| GHRS | GH RESEARCH PLC | 499,400 | $5.925M | 0.3% | $21.97 | -53.3% | ORDINARY SHARES | G3855L106 |
| CMPS | COMPASS PATHWAYS PLC | 678,360 | $5.617M | 0.3% | $8.28 | — | SPONSORED ADS | 20451W101 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 108,450 | $5.531M | 0.3% | $26.91 | 0.0% | CLASS A ORD | 61559X104 |
| IPSC | CENTURY THERAPEUTICS INC | 1,022,892 | $3.232M | 0.1% | $11.43 | -71.8% | COM | 15673T100 |
| HRTX | HERON THERAPEUTICS INC | 2,086,704 | $2.421M | 0.1% | $3.91 | -54.4% | COM | 427746102 |
| — | FIBROGEN INC | 764,700 | $2.065M | 0.1% | — | — | Call | 31572Q808 |
| — | ALLAKOS INC | 228,277 | $995K | 0.0% | $6.30 | — | COM | 01671P100 |
| IMUX | IMMUNIC INC | 308,314 | $774K | 0.0% | $1.86 | -9.7% | COM | 4525EP101 |
| — | MINK THERAPEUTICS INC | 324,867 | $682K | 0.0% | $2.10 | — | COM | 603693102 |